China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financi...(d Condensed Consolidated Statements of C...),Health

Date:9/1/2009

d Condensed Consolidated Statements of Cash Flows For the Years Ended March 31, March 31, 2008 2009 RMB RMB US$ (in thousands) Net cash provided by operating activities 463,334 490,758 71,823 Net cash used in investing activities (831,551) (1,467,195) (214,725) Net cash (used in) provided by financing activities (86,149) 1,751,297 256,303 Effect of foreign currency exchange rate change on cash (36,595) (1,129) (165) Net (decrease) increase in cash and cash equivalents (490,961) 773,731 113,236 Cash and cash equivalents: At beginning of year 1,173,640 682,679 99,911 At end of year 682,679 1,456,410 213,147 China Medical Technologies, Inc.

 Reconciliations of Non-GAAP Income from Continuing Operations to GAAP Income

                          from Continuing Operations

                                      For the Three Months Ended
                            March 31,   December 31,          March 31,
                              2008          2008                2009
                               RMB           RMB          RMB          US$
                            (in thousands except for per ADS information)

    GAAP income (loss)
     from continuing
     operations              51,799      (171,518)      56,274         8,236
    Adjustments:
    Stock compensation
     expense                  4,669        14,486       13,919         2,037
   
'/>"/>
SOURCE  China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI